Impact of pharmacist interventions on immunisation uptake: a systematic review and meta-analysis

Background Under-utilisation of immunisation services remains a public health challenge. Pharmacists act as facilitators and increasingly as immunisers, yet relatively little robust evidence exists of the impact elicited on patient health outcome and vaccination uptake. Objective To evaluate the inf...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamad Hafiz Abd Rahim (Author), Siti Hajar Mahamad Dom (Author), Mohd Shah Rezan Hamzah (Author), Siti Hawa Azman (Author), Zahirah Zaharuddin (Author), Mathumalar Loganathan Fahrni (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_62327fc3f0604da4a8d065ee0cbfda49
042 |a dc 
100 1 0 |a Mohamad Hafiz Abd Rahim  |e author 
700 1 0 |a Siti Hajar Mahamad Dom  |e author 
700 1 0 |a Mohd Shah Rezan Hamzah  |e author 
700 1 0 |a Siti Hawa Azman  |e author 
700 1 0 |a Zahirah Zaharuddin  |e author 
700 1 0 |a Mathumalar Loganathan Fahrni  |e author 
245 0 0 |a Impact of pharmacist interventions on immunisation uptake: a systematic review and meta-analysis 
260 |b Taylor & Francis Group,   |c 2024-12-01T00:00:00Z. 
500 |a 2052-3211 
500 |a 10.1080/20523211.2023.2285955 
520 |a Background Under-utilisation of immunisation services remains a public health challenge. Pharmacists act as facilitators and increasingly as immunisers, yet relatively little robust evidence exists of the impact elicited on patient health outcome and vaccination uptake. Objective To evaluate the influence of pharmacist interventions on public vaccination rate. Methods SCOPUS, PubMed, and Web of Science were searched from inception to April 2023 to retrieve non- and randomised controlled clinical trials (RCTs). Studies were excluded if no comparator group to pharmacist involvement was reported. Data extraction, risk of bias assessments, and meta-analyses using random-effect models, were performed. Results Four RCTs and 15 non-RCTs, encompassing influenza, pneumococcal, herpes zoster, and tetanus-diphtheria and pertussis vaccine types, and administered in diverse settings including community pharmacies, were included. Pooled effect sizes revealed that, as compared to usual care, pharmacists, regardless of their intervention, improved the overall immunisation uptake by up to 51% [RR 1.51 (1.28, 1.77)] while immunisation frequency doubled when pharmacists acted specifically as advocators [RR 2.09 (1.42, 3.07)]. Conclusion While the evidence for pharmacist immunisers was mixed, their contribution to immunisation programmes boosted public vaccination rate. Pharmacists demonstrated leadership and acquired indispensable advocator roles in the community and hospital settings. Future research could explore the depth of engagement and hence the extent of influence on immunisation uptake. 
546 |a EN 
690 |a vaccination 
690 |a primary prevention 
690 |a immunisation 
690 |a pharmacist 
690 |a advocator 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024) 
787 0 |n http://dx.doi.org/10.1080/20523211.2023.2285955 
787 0 |n https://doaj.org/toc/2052-3211 
856 4 1 |u https://doaj.org/article/62327fc3f0604da4a8d065ee0cbfda49  |z Connect to this object online.